University of Seoul Professor Yeol Ando's Team Secures Consecutive Selection for Quantum Medicine Project

A Series of Global Research Projects Secured in Succession

On April 22, the University of Seoul announced that the research team led by Professor Emeritus Yeol Ando of the Department of Electronic, Electrical, and Computer Engineering was selected as a finalist for the "Quantum Innovation Catalyst Program," co-hosted by the world-renowned medical institution Cleveland Clinic and global investment firm K5 Global.

Co-CEOs and Researchers (from left) Professor Jongchan Yoon, Department of Cardiology, Seoul St. Mary's Hospital; Professor Jeongim Jung, Department of Radiology; Dr. Kyunglim Han, Brain Science Institute, Korea Institute of Science and Technology (KIST); Honorary Chair Professor Yolyol Ahn, University of Seoul

This achievement is recognized as an international validation of the team's research capabilities, particularly their innovative approach to solving complex biomedical challenges that are difficult to address using conventional computing methods, through the use of quantum computing.

Notably, the University of Seoul research team was chosen through intense global competition, receiving high marks for the originality of their research, technological innovation, and commercial potential.

The research will be conducted in collaboration with major domestic and international institutions, including medical staff from Seoul St. Mary's Hospital at the Catholic University of Korea, the Korea Institute of Science and Technology (KIST), the National Quantum Laboratory (Q-Lab) at the University of Maryland in the United States, Amazon AWS, and Finnish quantum computing company IQM.

In addition, Singularity Quantum, a quantum technology specialist company, will participate in the project, further enhancing both the research and commercialization prospects.

The selected research topic is "Quantum Algorithms for Cardiovascular CT-FFR Simulation and Tumor Microcirculation Modeling." The project aims to dramatically improve diagnostic accuracy in precision medicine by leveraging quantum computing-based computational fluid dynamics technology.

The research results are expected to be applied not only to the diagnosis of cardiovascular diseases but also to key stages of new drug development, such as optimizing drug delivery within tumors.

The University of Seoul anticipates that this research could expand beyond the field of precision medicine to various industries, including aerospace fluid analysis and climate prediction.

In particular, the project is highly regarded for securing foundational technology that can significantly reduce both the cost and time required in the new drug development process.

Professor Ando has pioneered the field of quantum computing reliability by proposing quantum algorithms for the analysis of the Navier-Stokes equations as well as non-Markovian-based quantum error mitigation theory.

This latest research is also attracting attention as evidence of the team's competitiveness in the global research ecosystem, built upon these accumulated achievements.

A University of Seoul official stated, "Being selected for this program demonstrates that the University of Seoul now possesses world-class competitiveness in quantum computing-based medical research. We will continue to lead the development of next-generation core technologies through international collaborative research."

This content was produced with the assistance of AI translation services.